The majority of analyst ratings for Illumina are positive, with 2 bullish and 2 somewhat bullish ratings out of 5. This indicates a generally optimistic outlook for the stock. Additionally, the average 12-month price target has increased by 3.95% over the past month, suggesting that analysts are becoming more bullish on the stock. This is likely to have a positive short-term impact on Illumina's stock price.